EMERGENCY:A first seizure in any adult or older child in India requires MRI brain with contrast to look for NCC ring-enhancing lesions —call040-46324365immediately — 24 hours, 7 days— 24/7
Expert MRI diagnosis with scolex identification, albendazole and praziquantel antiparasitic protocols, corticosteroid co-therapy, seizure management, and neuroendoscopic surgery for intraventricular and racemose NCC at KIMS Neuroscience, Secunderabad, Hyderabad.
NCC is the most common helminth infection of the nervous system globally and the most common cause of acquired epilepsy in India, affecting approximately 1 million Indians. It results from accidental ingestion of Taenia solium (pork tapeworm) eggs from contaminated food or water. Vegetarians can and do get NCC — swallowing tapeworm eggs from contaminated vegetables or water (not from eating pork) causes NCC. The larvae form cysts in the brain parenchyma, ventricles, subarachnoid space, or spinal cord. Dying cysts provoke an inflammatory reaction producing seizures, headache, and raised ICP. In India, the most common presentation is a new-onset seizure in a previously well young adult. MRI shows a ring-enhancing lesion with a scolex (bright eccentric dot = pathognomonic of NCC). Treatment: albendazole + corticosteroid (always together) + antiseizure medication. Important exception: cysticercotic encephalitis requires corticosteroids FIRST before antiparasitics, to control cerebral oedema.
| Fact | Details |
|---|---|
| India burden | 1 million Indians with NCC-associated epilepsy · 1/3 of acquired epilepsy in India · Rs 12 billion annual economic burden · Endemic across India |
| Transmission | Faecal-oral · Swallowing Taenia solium eggs in contaminated food/water · NOT from eating pork · Vegetarians CAN get NCC · Food handler with intestinal tapeworm is a risk |
| Clinical presentation | Most common: new-onset adult seizure · Also: headache, raised ICP, hydrocephalus, focal deficit · Spinal NCC: limb weakness, bladder dysfunction |
| Diagnosis | MRI brain with contrast · Scolex (bright eccentric dot) = pathognomonic · Del Brutto criteria (2017): absolute, major, minor, epidemiological · ELISA serology supportive (low sensitivity for solitary lesions) |
| Treatment (parenchymal) | Albendazole 15mg/kg/day x 10–14 days · Praziquantel for multiple cysts · Corticosteroid (dexamethasone) ALWAYS with antiparasitic · Antiseizure medication |
| Cysticercotic encephalitis | Massive simultaneous cyst burden · DO NOT start antiparasitic first · IV dexamethasone first 1–2 weeks · Antiparasitic only after oedema controlled |
| Stopping antiseizure medication | Both criteria required: lesion resolved on MRI AND 12 months seizure-free · Then taper over 3–6 months · Intraventricular NCC: neuroendoscopic removal at KIMS |
The essential facts that shape how Neurocysticercosis is recognised, diagnosed, and managed at KIMS — from its India burden as the leading cause of acquired epilepsy, to how it is acquired (including in vegetarians), and the clinical presentations that bring patients to assessment.
Neurocysticercosis (NCC) is the most common helminth (worm) infection of the nervous system globally, and the most common preventable cause of acquired epilepsy in India. It results from infection of the human brain with the larval stage (cysticerci) of Taenia solium, the pork tapeworm. The larvae form cysts in the brain parenchyma, ventricles, subarachnoid space, or spinal cord. The immune response to dying cysts produces inflammation, seizures, headache, and sometimes raised intracranial pressure.
Population-based studies estimate approximately 1 million Indians with active epilepsy attributable to NCC. NCC causes approximately one-third of all cases of acquired epilepsy in India. The annual economic burden of NCC-associated epilepsy in India was estimated at Rs 12 billion (US$ 185 million). NCC is endemic across most of India, with higher prevalence in the north, though it occurs throughout the country including in Telangana and Hyderabad.
NCC is acquired by accidentally swallowing Taenia solium eggs from contaminated food or water. The eggs come from the faeces of a human who has intestinal tapeworm. Transmission is faecal-oral. Importantly: you do not need to eat pork to get NCC. Vegetarians can and do get NCC from contaminated vegetables or water. Eating pork can give you intestinal tapeworm (a different, asymptomatic condition); swallowing tapeworm eggs — from contaminated food or water, or from a tapeworm carrier in the household — gives you cysticercosis.
The most common presentation in India is a new-onset seizure (focal or generalised) in a previously well young adult with no family history of epilepsy. Other presentations: headache from cyst inflammation, raised intracranial pressure (from intraventricular or subarachnoid cysts), focal neurological deficits, or incidental finding on MRI done for other reasons. In children, focal seizures with a single enhancing lesion on MRI are the classic presentation.
040-44885000
A 24-year-old man in Hyderabad has a generalised tonic-clonic seizure while at his office. There is no family history of epilepsy. He drinks no alcohol, has had no head injury. His colleagues call an ambulance. He recovers fully within 20 minutes. He is referred to KIMS for evaluation of a first seizure.
At KIMS, the assessment follows a clear protocol. A first seizure in a young adult in India is NCC until proven otherwise. MRI brain with gadolinium is arranged the same day. It shows a single ring-enhancing lesion in the right parietal cortex, approximately 12mm, with surrounding oedema. A bright central dot within the cyst is visible on thin-cut sequences — this is the scolex (the head of the tapeworm larva), which is pathognomonic of NCC.
The diagnosis is NCC — a single enhancing lesion (SEL), the most common and most benign NCC form in India. He is started on: albendazole 15 mg/kg/day in two divided doses for 10–14 days (to kill the cyst), oral dexamethasone 0.1 mg/kg/day for the duration of albendazole (to control the inflammatory oedema that acyclovir provokes as the cyst dies), and carbamazepine 200mg twice daily for seizure prevention. He is told he is not permitted to drive for 6 months.
At 3-month follow-up MRI: the lesion has resolved completely. He has had no further seizures. After 12 months of seizure freedom and lesion resolution on MRI, his antiepileptic medication is tapered and stopped. This is the typical trajectory of single enhancing NCC in India — complete resolution with a defined treatment course, and no need for lifelong antiepileptics if lesions resolve and seizures are controlled.
Book a Consultation
Speak directly with our NCC specialist team — neurology, neurosurgery, neuroradiology, and infectious diseases coordinated under one roof. MRI with contrast available the same day for first-seizure presentations. No referral required. Monday to Saturday.
040-44885000Emergency: 040-46324365The cards below summarise the principal NCC types, their characteristic imaging features, the typical clinical context in which each is encountered, and the treatment approach used at KIMS for each form.
Imaging: Single ring-enhancing lesion with surrounding oedema, scolex often visible.
Clinical context: Most common form in India. Young adult, first seizure. Excellent prognosis.
Treatment: Albendazole 15 mg/kg/day × 10–14 days + corticosteroid + AED.
Imaging: Multiple ring/disc-enhancing lesions at various stages.
Clinical context: Variable; more lesions = more seizure burden.
Treatment: Albendazole + praziquantel combination + corticosteroid + AED.
Imaging: Innumerable cysts throughout brain producing diffuse cerebral oedema.
Clinical context: Severe, life-threatening. Children especially.
Treatment: Corticosteroids first; antiparasitics after oedema controlled.
Imaging: Large multi-lobulated cysts in the basal cisterns or ventricles; no scolex.
Clinical context: Severe; hydrocephalus common; requires surgical management.
Treatment: Surgery (shunt/endoscopy) + long-term albendazole.
Imaging: Cyst within ventricle causing intermittent obstructive hydrocephalus.
Clinical context: Intermittent severe headache + vomiting; life-threatening if obstructed.
Treatment: Endoscopic removal + shunt if residual hydrocephalus.
The clinical profile of neurocysticercosis spans new-onset seizures, cyst-related and inflammatory headache, raised intracranial pressure from intraventricular and basal cistern disease, and the long-term seizure relevance of calcified lesions — each of which is specifically assessed and managed at KIMS.
New-onset seizures are the presenting feature in approximately 70–80% of symptomatic NCC cases in India. The seizures reflect cortical irritation from the inflammatory reaction around the dying cyst. Focal-onset seizures (arising from one part of the brain) with or without secondary generalisation are the most common type. In the single enhancing lesion (SEL) — the most common form in India — seizures respond well to antiepileptics and tend to resolve as the lesion resolves, often allowing eventual medication withdrawal.
Headache occurs in approximately 40% of NCC patients. It may be from the local inflammatory reaction around active or dying cysts (associated with the lesion's location), from raised ICP in subarachnoid or ventricular NCC, or from cerebral oedema in cysticercotic encephalitis. Sudden severe headache with deterioration of consciousness suggests acute obstructive hydrocephalus from an intraventricular cyst — a surgical emergency.
Subarachnoid (racemose) NCC in the basal cisterns and intraventricular NCC produce hydrocephalus by obstructing CSF pathways. This causes progressive headache, vomiting, papilloedema, and declining consciousness. Racemose NCC — large, multi-lobulated grape-like cysts without a scolex — is particularly aggressive, growing within the subarachnoid space and producing basilar meningitis and cranial nerve palsies. Surgical management (VP shunting, endoscopic cyst removal) is required at KIMS.
Calcified NCC lesions represent dead, healed cysts and are a very common incidental finding on CT and MRI in India. They appear as small hyperdense (bright on CT) calcifications. While the cyst itself is dead, calcified NCC is not entirely benign — these calcifications are associated with a higher risk of seizures than the general population, possibly because of ongoing perilesional inflammation. At KIMS, calcified NCC found in a patient with new-onset seizures is treated as the cause even though the cyst is dead — antiepileptics are prescribed and the calcification is monitored.
Neurocysticercosis diagnosis at KIMS combines high-resolution MRI imaging (the cornerstone), supportive serology, structured application of the Del Brutto diagnostic criteria, and EEG for seizure characterisation — applied to the specific clinical picture of each presentation.
MRI brain with gadolinium using thin-cut sequences (1–3mm) through the lesion. Key MRI features: ring-enhancing cyst with surrounding oedema (active cyst); eccentric bright dot within the cyst on T1 or FLAIR = scolex = pathognomonic of NCC; calcified lesions on SWI/GRE; vesicular cysts (living cysts with no surrounding inflammation) on FLAIR; collapsed/degenerating cysts. Multiple stages simultaneously ("solarisation" pattern = cysts at different stages of death) is characteristic. CT brain identifies calcifications better than MRI but MRI is superior for all other NCC stages and for identifying the scolex.
EITB (Enzyme-linked Immunoelectrotransfer Blot) for anticysticercal antibodies: the most specific serology test, but sensitivity varies. A negative EITB does not exclude NCC (particularly single lesions, where EITB sensitivity is only approximately 50%). A positive EITB in the context of appropriate imaging is highly supportive. At KIMS, serology is used alongside imaging and clinical context, not as the sole diagnostic tool.
The revised Del Brutto diagnostic criteria (2017) use a combination of absolute, major, minor, and epidemiological criteria to classify cases as definitive, probable, or possible NCC. Absolute criteria: histopathology; characteristic cyst on neuroimaging with visible scolex; direct visualisation of subretinal cyst (ophthalmoscopy). Major criteria: solitary or multiple enhancing lesions; calcifications. Epidemiological: residence or travel to endemic area; household contact with T. solium tapeworm; pork-eating in endemic area. At KIMS, a clinical + imaging diagnosis is made in most cases without the need for biopsy.
EEG is arranged in all NCC patients presenting with seizures to characterise the seizure type and focus, guide antiseizure medication selection, and identify subclinical epileptiform activity. A focal slow wave or epileptiform discharge over the lesion site confirms the lesion as the seizure focus.
Single enhancing lesion: Albendazole 15 mg/kg/day in 2 divided doses (maximum 800mg/day) for 10–14 days. Coadminister with oral corticosteroids (dexamethasone 0.1 mg/kg/day or prednisolone 1 mg/kg/day) for the entire albendazole course — this controls the inflammatory reaction provoked by dying cysts that can worsen seizures and oedema.
Multiple parenchymal lesions: Albendazole + Praziquantel combination (praziquantel 50 mg/kg/day in 3 divided doses for 10–14 days, added to albendazole). More effective than albendazole alone for multiple lesions.
Cysticercotic encephalitis: Corticosteroids FIRST, high-dose dexamethasone IV to control cerebral oedema; antiparasitics started only after oedema is controlled, often after 1–2 weeks.
Carbamazepine 200–400mg twice daily or oxcarbazepine 300–600mg twice daily is first-line for focal NCC-associated seizures at KIMS. Levetiracetam 500–1,000mg twice daily is a well-tolerated alternative.
Duration: continued until (1) the lesion has resolved on follow-up MRI; AND (2) the patient has been seizure-free for at least 12 months on medication. Antiseizures are then tapered over 3–6 months if the MRI remains clear.
Intraventricular NCC: Neuroendoscopic removal of the intraventricular cyst is the treatment of choice. At KIMS, neuroendoscopy is performed for accessible intraventricular cysts. VP shunting is arranged for residual or recurrent hydrocephalus.
Racemose subarachnoid NCC: Long-term albendazole (prolonged courses, often 3–6 months with monitoring); corticosteroids for meningitis; VP shunt for hydrocephalus.
Spinal NCC: Surgical decompression for spinal cord compression from large cysts.
NCC is completely preventable. The transmission chain: human intestinal tapeworm carrier → tapeworm eggs in faeces → eggs contaminate food/water → another person swallows eggs → eggs hatch in the gut → larvae enter the bloodstream → larvae lodge in the brain. Breaking any link breaks the chain.
Particularly raw salads and produce that may have been in contact with contaminated water or fertiliser.
Boiled or filtered water. NCC is essentially a water and food hygiene disease.
Thorough handwashing before food preparation and eating, particularly by those who handle raw food or soil.
Thorough cooking kills cysticerci in pork and prevents intestinal tapeworm, which is the source of eggs for others.
If a family member is found to have intestinal tapeworm (Taenia solium), treatment with praziquantel or niclosamide protects other household members from NCC.
Related Conditions
Neurocysticercosis belongs to the family of infectious and post-infectious neurological disorders evaluated and managed at KIMS Neuroscience:
One-third of new epilepsy cases in India are caused by a brain infection that is completely preventable with food and water hygiene, and treatable in most forms with a 2-week course of albendazole.
At KIMS Neuroscience, Secunderabad, Hyderabad, every first seizure gets MRI with contrast, NCC is specifically identified and staged, and treatment is tailored to the NCC type — single enhancing lesion, multiple parenchymal cysts, cysticercotic encephalitis, racemose/subarachnoid, or intraventricular. Antiparasitic protocols are paired with corticosteroid co-therapy, antiseizure medication is continued until lesion resolution and 12 months of seizure freedom, and neuroendoscopic and shunt surgery are available for hydrocephalus and intraventricular disease. Call 040-44885000 for a first seizure assessment or NCC review. Emergency: 040-46324365.
International enquiries: info@kimsneurosciences.com